Evaluating of the phosphodiesterase inhibitor type 5 effectiveness in treatment of neurogenic erectile dysfunction in patients with DM type 1

D G Kurbatov; G R Galstyan; Yu G Shvarts; R V Rozhivanov; S A Dubskiy; A E Lepetukhin

doi:10.14341/probl7753-5579

For citations:

Kurbatov D.G., Galstyan G.R., Shvarts Yu.G., Rozhivanov R.V., Dubskiy S.A., Lepetukhin A.E. Evaluating of the phosphodiesterase inhibitor type 5 effectiveness in treatment of neurogenic erectile dysfunction in patients with DM type 1. Problems of Endocrinology. 2015;61(4):24-28. https://doi.org/10.14341/probl201561424-28

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Problems of Endocrinology

For citations:

Cookies policy